Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Behind Mylan's Mixed Q1 Results


You might say that Mylan (NASDAQ: MYL) is a company in waiting. At some point over the next few months, its merger with Pfizer's Upjohn will close. Mylan will be no more; a new company named Viatris will be created from the merger.

In the meantime, investors no longer have to wait to know how Mylan performed in the first quarter. The drugmaker announced its first-quarter results before the market opened on Monday. Here are the highlights from Mylan's Q1 update.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
MYL
Share

Comments